Indivior (NASDAQ:INDV) Hits New 12-Month Low at $9.14

Indivior PLC (NASDAQ:INDV)’s share price hit a new 52-week low during mid-day trading on Monday . The company traded as low as $9.14 and last traded at $9.14, with a volume of 120708 shares traded. The stock had previously closed at $9.48.

Analyst Upgrades and Downgrades

Several analysts have issued reports on INDV shares. Piper Sandler reiterated an “overweight” rating and issued a $22.00 target price on shares of Indivior in a research note on Friday, September 13th. Craig Hallum lowered their price target on Indivior from $37.00 to $24.00 and set a “buy” rating on the stock in a report on Wednesday, July 10th.

Indivior Stock Down 2.4 %

The company has a current ratio of 0.85, a quick ratio of 0.68 and a debt-to-equity ratio of 23.50. The stock has a market cap of $1.28 billion, a P/E ratio of 948.00 and a beta of 0.68. The stock’s fifty day moving average price is $11.69 and its 200 day moving average price is $15.84.

Indivior (NASDAQ:INDV) last released its quarterly earnings results on Thursday, July 25th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.04. The business had revenue of $299.00 million for the quarter, compared to the consensus estimate of $285.90 million. Indivior had a negative return on equity of 654.82% and a negative net margin of 12.29%. As a group, research analysts forecast that Indivior PLC will post 1.7 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its position in Indivior by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 5,899,190 shares of the company’s stock worth $90,081,000 after acquiring an additional 52,836 shares during the last quarter. Norges Bank bought a new position in shares of Indivior in the fourth quarter worth approximately $36,011,000. Toronto Dominion Bank increased its stake in shares of Indivior by 58.0% in the first quarter. Toronto Dominion Bank now owns 2,094,865 shares of the company’s stock worth $44,872,000 after buying an additional 769,000 shares during the period. Premier Fund Managers Ltd grew its holdings in Indivior by 17.8% in the 4th quarter. Premier Fund Managers Ltd now owns 850,980 shares of the company’s stock worth $12,901,000 after acquiring an additional 128,611 shares during the last quarter. Finally, UBS Group AG increased its position in shares of Indivior by 71.9% in the fourth quarter. UBS Group AG now owns 826,130 shares of the company’s stock valued at $12,615,000 after acquiring an additional 345,556 shares during the period. 60.33% of the stock is owned by hedge funds and other institutional investors.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.